Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Amyotrophic lateral sclerosis progression: Iran-ALS clinical registry, a multicentre study.
Shamshiri H, Fatehi F, Davoudi F, Mir E, Pourmirza B, Abolfazli R, Etemadifar M, Harirchian MH, Gharagozli K, Ayromlou H, Basiri K, Zamani B, Rohani M, Sedighi B, Roudbari A, Delavar Kasmaei H, Nikkhah K, Ranjbar Naeini A, Nafissi S. Shamshiri H, et al. Among authors: sedighi b. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16(7-8):506-11. doi: 10.3109/21678421.2015.1074698. Epub 2015 Oct 5. Amyotroph Lateral Scler Frontotemporal Degener. 2015. PMID: 26437387
Iranian consensus on use of vitamin D in patients with multiple sclerosis.
Jahromi SR, Sahraian MA, Togha M, Sedighi B, Shayegannejad V, Nickseresht A, Nafissi S, Mohebbi N, Majdinasab N, Foroughipour M, Etemadifar M, Moghadam NB, Ayramlou H, Ashtari F, Alaie S. Jahromi SR, et al. Among authors: sedighi b. BMC Neurol. 2016 May 21;16:76. doi: 10.1186/s12883-016-0586-3. BMC Neurol. 2016. PMID: 27209163 Free PMC article. Review.
Trends of quality of life changes in amyotrophic lateral sclerosis patients.
Shamshiri H, Fatehi F, Abolfazli R, Harirchian MH, Sedighi B, Zamani B, Roudbari A, Razazian N, Khamseh F, Nafissi S. Shamshiri H, et al. Among authors: sedighi b. J Neurol Sci. 2016 Sep 15;368:35-40. doi: 10.1016/j.jns.2016.06.056. Epub 2016 Jun 25. J Neurol Sci. 2016. PMID: 27538598
Safety and efficacy of fingolimod in Iranian patients with relapsing-remitting multiple sclerosis: An open-label study.
Doosti R, Naser Moghadasi A, Azimi AR, Karbalai Saleh S, Etemadifar M, Shaygannejad V, Ashtari F, Harirchian MH, Siroos SB, Ayramloo H, Majdinasab N, Hojjati SMM, Asghari N, Baghbanian SM, Cheraghmakani H, Abedini M, Sedighi B, Mohseni Abbas Abadi N, Ghasemitabar M, Talebianpour S, Babayi Daylari T, Dana V, Ghaleh Noie N, Sahraian MA. Doosti R, et al. Among authors: sedighi b. Caspian J Intern Med. 2021 Apr;12(3):263-274. doi: 10.22088/cjim.12.3.263. Caspian J Intern Med. 2021. PMID: 34221275 Free PMC article.
Zytux in Refractory Myasthenia Gravis: A Multicenter, Open-Labeled, Clinical Trial Study of Effectiveness and Safety of a Rituximab Biosimilar.
Fatehi F, Moradi K, Okhovat AA, Shojatalab G, Sedighi B, Boostani R, Sarraf P, Haghi Ashtiani B, Ghasemi M, Moussavi S, Anjidani N, Nafissi S. Fatehi F, et al. Among authors: sedighi b. Front Neurol. 2021 Aug 26;12:682622. doi: 10.3389/fneur.2021.682622. eCollection 2021. Front Neurol. 2021. PMID: 34512504 Free PMC article.
Safety and Effectiveness of Cinnomer® on Disease Characteristics, Depression, and Quality of Life of Patients with Multiple Sclerosis: A Phase IV, Post-marketing, Prospective, Multicenter Study.
Naser Moghadasi A, Ashtari F, Baghbanian SM, Shaygannejad V, Anjidani N, Ghadiri F, Sedighi B, Saeidi M, Amirifard H, Ayromlou H, Beladi Moghadam N, Ranjbar MB, Nazeri M, Niknam Z, Faraji F, Afsorde A, Sahraian MA. Naser Moghadasi A, et al. Among authors: sedighi b. Arch Iran Med. 2023 Nov 1;26(11):647-653. doi: 10.34172/aim.2023.95. Arch Iran Med. 2023. PMID: 38310425 Free PMC article. Clinical Trial.
31 results